About Dr. Robin L. Smith

A Global Leader in Advancing Health and Accelerating Cures

Robin L. Smith, MD, MBA, is an internationally recognized physician, entrepreneur, and global health advocate dedicated to transforming the future of medicine. As Chairman, CEO, and President of The Cura Foundation, she leads one of the world’s most influential nonprofit organizations focused on improving human health, reducing suffering, and accelerating the development of effective cures.

Dr. Smith has built a global reputation for bringing together leaders across science, medicine, philanthropy, technology, industry, ethics, and policy to collaborate on solutions for humanity’s most pressing health challenges.

Leadership of The Cura Foundation

Under Dr. Smith’s direction, The Cura Foundation has become a central convener in the global health landscape. Cura is widely known for hosting the Vatican’s landmark Unite to Cure, Unite to Prevent, and related conferences—historic gatherings that unite Nobel laureates, pioneering researchers, clinicians, global CEOs, investors, patient advocates, and faith leaders.

These international forums focus on accelerating breakthroughs in:

• Regenerative medicine, cell and gene therapy

• Longevity science and preventive medicine

• AI and digital innovation in healthcare

• Rare diseases and precision therapeutics

• Global wellness, mental health, and public health access

• Ethical and responsible pathways for medical advancement

Dr. Smith has positioned Cura as a trusted, nonsectarian partner working across borders, sectors, and disciplines to advance medical progress.

Entrepreneurship & Medical Innovation

A pioneer in translating scientific discoveries into practical therapeutic solutions, Dr. Smith has founded, chaired, or advised numerous companies in:

• Biotechnology

• Regenerative medicine

• Medical devices and diagnostics

• Digital health

• Life science commercialization

Her leadership spans strategy, clinical development, innovation governance, and impactful public–private partnerships.

She currently serves in several executive and advisory roles, including:

• Chairman, Alphagen Group

• Co-Founder, Spiritus Medical

• Advisor to multiple companies in regenerative medicine, AI-driven health technologies, and precision therapeutics

Dr. Smith is recognized globally for her ability to translate breakthrough science into solutions that reach patients faster.

Author & Thought Leader

Dr. Smith is the New York Times bestselling co-author of The Healing Cell, a foundational resource explaining the promise of regenerative medicine and emerging therapies to the public.
She is a frequent contributor to major media outlets and scientific platforms, speaking on:

• Medical innovation and regenerative technologies

• The future of global health

• Ethical considerations in biotechnology

• AI and digital transformation in medicine

• Patient-centric innovation and health equity

Her work continues to shape public understanding and advance meaningful conversations across science, policy, and thought leadership.

Education & Training

Dr. Smith holds distinguished academic credentials, including:

• MD, Yale School of Medicine

• Residency, Mount Sinai Medical Center (Internal Medicine)

• MBA, The Wharton School of the University of Pennsylvania

Her training reflects a rare combination of medical expertise, business acumen, and systems-level vision.

A Mission to Improve Human Health

Across all of her roles, Dr. Smith’s mission remains constant:
to build a global movement that accelerates cures, uplifts patients, and advances a more hopeful, equitable, and innovative future for human health.

Through The Cura Foundation, she continues to lead transformative collaborations that bring the world’s brightest minds together—turning possibility into progress and science into solutions for all.